Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Nine-year follow-up of balloon-expandable Palmaz-Schatz stent in patients with single-vessel disease
Autore:
Karam, C; Fajadet, J; Beauchet, A; Cassagneau, B; Marco, J;
Indirizzi:
Hop Ambroise Pare, Serv Cardiol, F-92100 Boulogne, France Hop Ambroise Pare Boulogne France F-92100 diol, F-92100 Boulogne, France Clin Pasteur, Intervent Cardiol Unit, Toulouse, France Clin Pasteur Toulouse France , Intervent Cardiol Unit, Toulouse, France Hop Ambroise Pare, Dept Comp Sci, F-92100 Boulogne, France Hop Ambroise Pare Boulogne France F-92100 Sci, F-92100 Boulogne, France
Titolo Testata:
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
fascicolo: 2, volume: 50, anno: 2000,
pagine: 170 - 174
SICI:
1522-1946(200006)50:2<170:NFOBPS>2.0.ZU;2-E
Fonte:
ISI
Lingua:
ENG
Soggetto:
CORONARY-ARTERY STENTS; DIABETES-MELLITUS; IMPLANTATION; ANGIOPLASTY; PLACEMENT; EXPERIENCE; OUTCOMES; TRIAL;
Keywords:
coronary artery disease; intracoronary stents; Palmaz-Schatz; long-term outcome;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
18
Recensione:
Indirizzi per estratti:
Indirizzo: Karam, C Hop Ambroise Pare, Serv Cardiol, 9 Ave Charles Gaulle, F-92100 Boulogne, France Hop Ambroise Pare 9 Ave Charles Gaulle Boulogne France F-92100 e
Citazione:
C. Karam et al., "Nine-year follow-up of balloon-expandable Palmaz-Schatz stent in patients with single-vessel disease", CATHET C IN, 50(2), 2000, pp. 170-174

Abstract

The long-term effects of intracoronary stents in human are unknown. This is the first g-year follow-up report of single-vessel-disease patients treated with the Palmaz-Schatz stent. Between March and December 1989, out of the 107 patients undergoing Palmaz-Schatz stent implantation, 71 (66%) had single-vessel disease. The average age of these patients was 58 +/- 9 years and 79% were men. At 9 years, follow-up was obtained for 90.1% and major adverse clinical events consisted of 4 deaths giving a global survival rate of95.8%, 7 myocardial infarction, 3 bypass surgeries, and 16 repeat percutaneous revascularization procedures. The 9-year event-free survival rate was 60%, and 81.7% of the patients were free from death, myocardial infarction,and bypass surgery. Multivariate analysis showed that the only predictive factor of major adverse clinical events was the presence of diabetes mellitus (P < 0.004). (C) 2000 Wiley-Liss, Inc.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 02/04/20 alle ore 20:42:31